Literature DB >> 25511352

Sickle cell disease clinical phenotypes in children from South-Western, Nigeria.

S A Adegoke1, O O Adeodu, A D Adekile.   

Abstract

BACKGROUND: The clinical phenotypes of children with sickle cell disease (SCD) are poorly described in many sub-Saharan countries including Nigeria.
OBJECTIVES: The objective was to highlight various clinical phenotypes of SCD in children and investigate the influence of sociodemographic indices on the development of SCD complications.
METHODS: We carried out a cross-sectional study of 240 pediatric patients attending the sickle cell clinic and the emergency room in a teaching hospital in South-Western Nigeria over a 12-month period. The clinical phenotypes and severity of the disease were documented, and the influence of sociodemographic variables was investigated.
RESULTS: The five leading clinical phenotypes in our patients were significant pain episodes, that is, vaso-occlusive crisis in 159 (66.3%); anemic crisis in 62 (25.8%); severe bacterial infections, 57 (23.8%); acute chest syndrome (ACS), 27 (11.3%) and stroke, 7 (2.9%). Forty-two (33.1%) had a previous history of dactylitis (hand-foot syndrome). Other clinical phenotypes such as avascular necrosis of the femur, 4 (1.7%); nephropathy, 2 (0.8%); priapism, gallstone and chronic leg ulcer, one (0.4%) each, were not commonly seen. More children with a history of asthma had ACS. Furthermore, high steady-state white blood cell count was associated with severe disease.
CONCLUSION: The clinical phenotypes of SCD in children from South-Western Nigeria are highly variable with the disease manifesting very early and about 10% having significant complications. Sociodemographic characteristics appear to have little influence on the development of SCD complications among our patients, but age and low-socioeconomic class are associated with anemic crisis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25511352     DOI: 10.4103/1119-3077.146987

Source DB:  PubMed          Journal:  Niger J Clin Pract            Impact factor:   0.968


  15 in total

1.  Complications of sickle cell anaemia in children in Northwestern Tanzania.

Authors:  Hamza Saidi; Luke R Smart; Erasmus Kamugisha; Emmanuela E Ambrose; Deogratias Soka; Robert N Peck; Julie Makani
Journal:  Hematology       Date:  2016-02-17       Impact factor: 2.269

2.  Hydroxyurea therapy in adult Nigerian sickle cell disease: a monocentric survey on pattern of use, clinical effects and patient's compliance.

Authors:  Ademola Samson Adewoyin; Omokiniovo Sunday Oghuvwu; Omolade Augustina Awodu
Journal:  Afr Health Sci       Date:  2017-03       Impact factor: 0.927

3.  Fixed Low-Dose Hydroxyurea for the Treatment of Adults with Sickle Cell Anemia in Nigeria.

Authors:  Bamidele O Tayo; Titilola S Akingbola; Santosh L Saraf; Binal N Shah; Chinedu A Ezekekwu; Omowunmi Sonubi; Lewis L Hsu; Richard S Cooper; Victor R Gordeuk
Journal:  Am J Hematol       Date:  2018-05-14       Impact factor: 10.047

4.  Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database.

Authors:  Hezekiah Isa; Samuel Adegoke; Anazoeze Madu; Abdul-Aziz Hassan; Chinatu Ohiaeri; Reuben Chianumba; Biobele Brown; Emmanuel Okocha; Ngozi Ugwu; Ijeoma Diaku-Akinwumi; Titilope Adeyemo; Aisha Kuliya-Gwarzo; Livingstone Dogara; Haliru Lawal; Yohanna Tanko; Adama Ladu; Umar Kangiwa; Lilian Ekwem; Seyi Oniyangi; Tambi Wakama; Domic Umoru; Olaniyi Olanrewaju; Norah Akinola; Uche Nnebe-Agumadu; Samuel Asala; Adekunle Adekile; John Olaniyi; Raphael Sangeda; Obiageli Nnodu
Journal:  Blood Cells Mol Dis       Date:  2020-04-23       Impact factor: 2.372

5.  Socioeconomic and demographic characteristics of sickle cell disease patients from a low-income region of northeastern Brazil.

Authors:  Thales Allyrio Araújo de Medeiros Fernandes; Tereza Maria Dantas de Medeiros; Jayra Juliana Paiva Alves; Christiane Medeiros Bezerra; José Veríssimo Fernandes; Édvis Santos Soares Serafim; Maria Zélia Fernandes; Maria de Fatima Sonati
Journal:  Rev Bras Hematol Hemoter       Date:  2015-04-14

6.  Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia.

Authors:  Milena Magalhães Aleluia; Caroline Conceição da Guarda; Rayra Pereira Santiago; Teresa Cristina Cardoso Fonseca; Fábia Idalina Neves; Regiana Quinto de Souza; Larissa Alves Farias; Felipe Araújo Pimenta; Luciana Magalhães Fiuza; Thassila Nogueira Pitanga; Júnia Raquel Dutra Ferreira; Elisângela Vitória Adorno; Bruno Antônio Veloso Cerqueira; Marilda de Souza Gonçalves
Journal:  Lipids Health Dis       Date:  2017-04-11       Impact factor: 3.876

7.  Stroke Prevalence in Children With Sickle Cell Disease in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.

Authors:  Lianna J Marks; Deogratias Munube; Philip Kasirye; Ezekiel Mupere; Zhezhen Jin; Philip LaRussa; Richard Idro; Nancy S Green
Journal:  Glob Pediatr Health       Date:  2018-05-14

8.  Comparative study of sickle cell anemia and hemoglobin SC disease: clinical characterization, laboratory biomarkers and genetic profiles.

Authors:  Milena Magalhães Aleluia; Teresa Cristina Cardoso Fonseca; Regiana Quinto Souza; Fábia Idalina Neves; Caroline Conceição da Guarda; Rayra Pereira Santiago; Bruna Laís Almeida Cunha; Camylla Villas Boas Figueiredo; Sânzio Silva Santana; Silvana Sousa da Paz; Júnia Raquel Dutra Ferreira; Bruno Antônio Veloso Cerqueira; Marilda de Souza Gonçalves
Journal:  BMC Hematol       Date:  2017-09-15

Review 9.  Neurologic complications of sickle cell disease in Africa: A systematic review and meta-analysis.

Authors:  Jean Jacques Noubiap; Michel K Mengnjo; Nicolas Nicastro; Joseph Kamtchum-Tatuene
Journal:  Neurology       Date:  2017-09-01       Impact factor: 9.910

10.  Chronic complications and quality of life of patients living with sickle cell disease and receiving care in three hospitals in Cameroon: a cross-sectional study.

Authors:  Anne M Andong; Eveline D T Ngouadjeu; Cavin E Bekolo; Vincent S Verla; Daniel Nebongo; Yannick Mboue-Djieka; Simeon-Pierre Choukem
Journal:  BMC Hematol       Date:  2017-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.